In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
As of close of business last night, Arcutis Biotherapeutics Inc’s stock clocked out at $13.58, down -3.96% from its previous closing price of $14.14. In other words, the price has decreased by -$3.96 from its previous closing price. On the day, 1.31 million shares were traded.
Ratios:
To gain a deeper understanding of ARQT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.37 and its Current Ratio is at 3.55. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.77.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 30, 2024, initiated with a Buy rating and assigned the stock a target price of $19.
On August 28, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $15.
Mizuho Upgraded its Neutral to Buy on January 03, 2024, whereas the target price for the stock was revised from $4 to $8.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 28 ’25 when Matsuda Masaru bought 1,800 shares for $13.78 per share.
Heron Patrick J bought 2,520 shares of ARQT for $34,423 on May 21 ’25. The Director now owns 20,014 shares after completing the transaction at $13.66 per share. On May 22 ’25, another insider, Heron Patrick J, who serves as the Director of the company, bought 2,520 shares for $13.65 each. As a result, the insider paid 34,398 and bolstered with 22,534 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 7.61 while its Price-to-Book (P/B) ratio in mrq is 11.34.
Stock Price History:
Over the past 52 weeks, ARQT has reached a high of $17.75, while it has fallen to a 52-week low of $6.99. The 50-Day Moving Average of the stock is -7.10%, while the 200-Day Moving Average is calculated to be 10.02%.
Shares Statistics:
A total of 119.14M shares are outstanding, with a floating share count of 104.84M. Insiders hold about 12.05% of the company’s shares, while institutions hold 99.03% stake in the company.
